sertraline has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, HT; Chen, IS; Chou, CT; Ho, CM; Huang, JK; Jan, CR; Kuo, CC; Liao, WC; Lin, KL; Liu, SI; Lu, YC; Shu, SS; Tsai, JY; Wang, JL | 1 |
| Waterfield, KE; Whipp, MJ | 1 |
2 other study(ies) available for sertraline and Cancer of Prostate
| Article | Year |
|---|---|
The mechanism of sertraline-induced [Ca(2+) ](i) rise in human PC3 prostate cancer cells.
Topics: Antidepressive Agents; Apoptosis; Calcium; Calcium Signaling; Cell Line, Tumor; Cell Survival; Humans; Male; Manganese; Prostatic Neoplasms; Sertraline; Type C Phospholipases | 2011 |
Serotonin syndrome in the differential diagnosis of spinal cord compression.
Topics: Aged; Aged, 80 and over; Depression; Diagnosis, Differential; Humans; Male; Prostatic Neoplasms; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline; Spinal Cord Compression; Spinal Neoplasms | 2004 |